RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models

por Garner, Fiona, Shomali, Maysoun, Paquin, Dotty, Lyttle, C. Richard, Hattersley, Gary
Publicado 2015